Efficacy of co-medications in patients with alcoholic liver disease
Background: Alcoholic liver disease (ALD) is still increasing and leads to acute liver injury but also liver cirrhosis and subsequent complications such as liver failure or hepatocellular carcinoma (HCC). As most patients fail to achieve alcohol abstinence, it is essential to identify alternative tr...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
September 2023
|
| In: |
Digestive diseases
Year: 2023, Jahrgang: 41, Heft: 5, Pages: 780-788 |
| ISSN: | 1421-9875 |
| DOI: | 10.1159/000529914 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1159/000529914 Verlag, lizenzpflichtig, Volltext: https://karger.com/ddi/article/41/5/780/853508/Efficacy-of-Co-Medications-in-Patients-with |
| Verfasserangaben: | Timo Itzel, Thomas Falconer, Ana Roig, Jimmy Daza, Jimyung Park, Jae Youn Cheong, Rae Woong Park, Isabella Wiest, Matthias P. Ebert, George Hripcsak, Andreas Teufel |
Search Result 1
Efficacy of co-medications in patients with alcoholic liver disease
Karger 2023
Article (Journal)
Book/Monograph
Online Resource